| abstract |
PROBLEM TO BE SOLVED: To provide a method and biomarker for detecting invasively from breast cancer, pancreatic cancer or non-small cell lung cancer from a subject, a method for diagnosing a disease with gene expression of PRDM14, a therapeutic agent for a disease targeting PRDM14 The present invention provides a method of evaluating the efficacy of C., a method of determining a therapeutic course for a disease, and / or a method of determining a prognosis after treatment of a disease. SOLUTION: The expression of PRDM14 gene is detected from blood or lymph collected from a subject (1) PRDM14 positive CTC expressing PRDM14 gene, or (2) leptin receptor (LEPR), macrophage A method for confirming the concentration by measuring the concentration of at least one protein selected from the group consisting of a derived chemokine (MDC) and an interferon γ (IFN γ). 【Selection chart】 None |